- page

Scroll to explore

Scroll back top

Domain Therapeutics to participate in the J.P. Morgan 39th Annual Healthcare Conference 2021 DIGITAL

8 December 2020

Domain Therapeutics launches Phase 1-enabling studies on proprietary EP4 receptor antagonist progra...

1 December 2020

Meet&Match 2020 immuno-oncology

20 October 2020

BIO-EUROPE 2020 digital meeting

13 October 2020

Join our free webinar : Innovative Technology for Insights into Receptor Tyrosine Kinase Biology ...

Shedding New Light on GPCR Drug Discovery with a Novel Biosensor Technology

8 September 2020

Join our free webinar : Shedding new light on GPCR drug discovery with a novel biosensor technology ...

1 September 2020

Domain Therapeutics enters into a new collaboration agreement with Pfizer Inc. to profile signaling ...

Domain Therapeutics presents posters at the American Association for Cancer Research Virtual Annual ...

Domain presents the last generation of bioSens-All™ platform dedicated to checkpoint inhibitors at...